Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05358379 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 330 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Cyclacel Pharmaceuticals, Inc. |
| Last Updated on CT.gov | February 7, 2024 (Feb 7, 2024) |
As of March 2, 2026: Clinical trial NCT05358379 is currently recruiting participants. This clinical trial study for cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Cyclacel Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05358379 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05358379 was last updated Feb 7, 2024 (February 7, 2024). HelloStudys verifies this status automatically.